Gheyath Nasrallah
Overview
Explore the profile of Gheyath Nasrallah including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
212
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Al-Dewik N, Samara M, Mahmah A, Al-Dewik A, Abou Nahia S, Abukhadijah H, et al.
Sci Rep
. 2024 Nov;
14(1):27107.
PMID: 39511221
The impact of Bariatric Surgery (BS) on maternal and neonatal outcomes among pregnant women is not fully understood, especially in comparison to different weight categories. The primary aim of this...
2.
Al-Dewik N, Abuarja T, Younes S, Nasrallah G, Alsharshani M, Ibrahim F, et al.
Per Med
. 2024 Sep;
21(5):313-333.
PMID: 39347749
Precision Medicine (PM) is a transformative clinical medicine strategy that aims to revolutionize healthcare by leveraging biological information and biomarkers. In the context of maternal and neonatal health, PM enables...
3.
Nabhan F, Fayyad E, Sliem M, Shurrab F, Eid K, Nasrallah G, et al.
ACS Omega
. 2023 Jul;
8(25):22361-22381.
PMID: 37396246
A carbon nitride (CN) nanomaterial has superior mechanical, thermal, and tribological properties, which make them attractive for various applications, including corrosion-resistant coatings. In this research, newly synthesized CN nanocapsules with...
4.
Al-Sharshani D, Velayutham D, Samara M, Gazal R, Al Haj Zen A, Ismail M, et al.
Mol Genet Genomic Med
. 2023 May;
11(8):e2178.
PMID: 37147786
Background: Dyslipidemia is recognized as one of the risk factors of cardiovascular diseases (CVDs), type 2 diabetes mellitus (T2DM), and non-alcoholic fatty liver disease (NAFLD). Objective: The study aimed to...
5.
Al-Dewik N, Samara M, Younes S, Al-Jurf R, Nasrallah G, Al-Obaidly S, et al.
Sci Rep
. 2023 Feb;
13(1):2198.
PMID: 36750603
Congenital anomalies (CAs) are a leading cause of morbidity and mortality in early life. We aimed to assess the incidence, risk factors, and outcomes of major CAs in the State...
6.
Vogt A, Augusto G, Martina B, Chang X, Nasrallah G, Speiser D, et al.
Vaccines (Basel)
. 2022 May;
10(5).
PMID: 35632499
In this report, we mechanistically reveal how the Variant of Concern (VOC) SARS-CoV-2 Omicron (B.1.1.529) escapes neutralizing antibody responses, by physio-chemical characterization of this variant in comparison to the wild-type...
7.
Slika H, Mansour H, Wehbe N, Nasser S, Iratni R, Nasrallah G, et al.
Biomed Pharmacother
. 2022 Jan;
146:112442.
PMID: 35062053
Cancer is a leading cause of morbidity and mortality around the globe. Reactive oxygen species (ROS) play contradicting roles in cancer incidence and progression. Antioxidants have attracted attention as emerging...
8.
Younes S, Samara M, Salama N, Al-Jurf R, Nasrallah G, Al-Obaidly S, et al.
PLoS One
. 2021 Oct;
16(10):e0258967.
PMID: 34710154
Background: Abnormal fetal growth can be associated with factors during pregnancy and at postpartum. Objective: In this study, we aimed to assess the incidence, risk factors, and feto-maternal outcomes associated...
9.
Mohsen M, Rothen D, Balke I, Martina B, Zeltina V, Inchakalody V, et al.
NPJ Vaccines
. 2021 Aug;
6(1):107.
PMID: 34429427
MERS-CoV continues to cause human outbreaks, so far in 27 countries worldwide following the first registered epidemic in Saudi Arabia in 2012. In this study, we produced a nanovaccine based...
10.
Younes S, Samara M, Al-Jurf R, Nasrallah G, Al-Obaidly S, Salama H, et al.
Int J Environ Res Public Health
. 2021 Jun;
18(11).
PMID: 34072575
Preterm birth (PTB) and early term birth (ETB) are associated with high risks of perinatal mortality and morbidity. While extreme to very PTBs have been extensively studied, studies on infants...